ImageneBio (IMA) Treasury Shares (2020 - 2025)
ImageneBio (IMA) posted Treasury Shares of $2.2 million for Q2 2025, little changed sequentially from $2.2 million in Q1 2025, and little changed YoY from $2.2 million in Q2 2024.
ImageneBio (IMA) Treasury Shares (2020 - 2025) Analysis & Trends
ImageneBio has reported Treasury Shares for 5 years, with the latest figure at $2.2 million in Q2 2025.
- Quarterly Treasury Shares changed 0.0% year-over-year to $2.2 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $2.2 million (changed 0.0% YoY) and the FY2024 annual result came in at $2.2 million, changed 0.0% from the prior year.
- Treasury Shares was little changed at $2.2 million in Q2 2025 per IMA's latest filing, from $2.2 million in the prior quarter.
- Over five years, Treasury Shares peaked at $35.9 million in Q2 2021 and troughed at $2.2 million in Q4 2023.
- A 4-year average of $6.1 million and a median of $2.2 million in 2023 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2021 and 2024: Treasury Shares tumbled 52.65% in 2021, then changed 0.0% in 2024.
- Over 4 years, Treasury Shares stood at $35.9 million in 2021, then tumbled by 93.97% to $2.2 million in 2023, then changed by 0.0% to $2.2 million in 2024, then changed by 0.0% to $2.2 million in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered $2.2 million, $2.2 million, and $2.2 million for Q2 2025, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | ImageneBio | 47.79 Mn | -87.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.16 Mn |
| Jun 30, 2025 | 2.16 Mn |
| Mar 31, 2025 | 2.16 Mn |
| Mar 31, 2025 | 2.16 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | 2.16 Mn |
| Mar 31, 2024 | 2.16 Mn |
| Mar 31, 2024 | 2.16 Mn |
| Dec 31, 2023 | 2.16 Mn |
| Dec 31, 2023 | 2.16 Mn |
| Sep 30, 2023 | 4.15 Mn |
| Sep 30, 2023 | 4.15 Mn |
| Jun 30, 2021 | 35.86 Mn |
| Jun 30, 2021 | 35.86 Mn |
| Dec 31, 2020 | 169.40 Mn |
| Dec 31, 2020 | 169.40 Mn |